Our company seeks seed capital of $500K to develop a breakthrough product that will revolutionize the medical diagnostics industry. Our product uses optical methods for non-invasive blood analysis. No blood draws! This device will take readings of blood component concentrations such as Glucose from the conjunctiva using a customized micro-spectrometer, provide instant results, and store patient data in a cloud database.